[Obesity in children and its relationship with chronic kidney disease]

Jessie Nallely Zurita-Cruz1, Miguel Ángel Villasís-Keever

  • 1Servicio de Escolares y Adolescentes, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México. miguel.villasis@imss.gob.mx.

Insights

Obesity increasingly impacts kidney health, especially in children. Early weight management is crucial to prevent chronic kidney disease (CKD) and reduce future patient numbers.

Area of Science:

  • Nephrology
  • Pediatrics
  • Metabolic Diseases

Background:

  • Global rise in obesity and chronic kidney disease (CKD) observed in parallel.
  • Obesity is linked to type 2 diabetes mellitus, hypertension, and reduced insulin sensitivity, directly impacting renal health.
  • Growing evidence links increased Body Mass Index (BMI) to the development of End-Stage Renal Disease (ESRD).

Purpose of the Study:

  • To review the impact of obesity on renal damage, with a focus on pediatric populations.
  • To elucidate the pathophysiological mechanisms linking obesity to kidney disease.
  • To highlight the importance of early intervention for weight management in preventing CKD.

Main Methods:

  • Review of epidemiological studies and pathophysiological mechanisms.
  • Focus on research concerning obesity and renal damage in both adult and pediatric populations.
  • Analysis of intervention studies demonstrating the effects of weight loss on renal parameters.

Main Results:

  • Reduced insulin sensitivity in obesity exacerbates renal damage through mechanisms like glomerular hyperfiltration, hypertrophy, and increased inflammation.
  • Studies indicate that weight loss interventions can reduce proteinuria, lower blood pressure, and improve glomerular filtration rate.
  • While adult data is extensive, pediatric data, though scarce, aligns with adult findings regarding obesity's detrimental effects on kidneys.

Conclusions:

  • Obesity poses a significant threat to kidney health, particularly in children.
  • Pathophysiological pathways driven by insulin resistance and inflammation contribute to obesity-related kidney damage.
  • Proactive strategies to combat childhood obesity are essential for future CKD prevention.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
590
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
906
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
272
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
333
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K